vs

Side-by-side financial comparison of Intuitive Surgical (ISRG) and Lam Research (LRCX). Click either name above to swap in a different company.

Lam Research is the larger business by last-quarter revenue ($5.3B vs $2.8B, roughly 1.9× Intuitive Surgical). Lam Research runs the higher net margin — 29.8% vs 29.8%, a 0.0% gap on every dollar of revenue. On growth, Intuitive Surgical posted the faster year-over-year revenue change (23.0% vs 22.1%). Over the past eight quarters, Lam Research's revenue compounded faster (18.7% CAGR vs 17.4%).

Intuitive Surgical, Inc. is an American biotechnology company that develops, manufactures, and markets robotic products designed to improve clinical outcomes of patients through minimally invasive surgery, most notably with the da Vinci Surgical System. The company is part of the Nasdaq-100, S&P 100 and S&P 500. As of 31 December 2021, Intuitive Surgical had an installed base of 6,730 da Vinci Surgical Systems, including 4,139 in the U.S.

Lam Research Corporation is an American supplier of wafer-fabrication equipment and related services to the semiconductor industry. Its products are used primarily in front-end wafer processing, which involves the steps that create the active components of semiconductor devices and their wiring (interconnects). The company also builds equipment for back-end wafer-level packaging (WLP) and for related manufacturing markets such as for microelectromechanical systems (MEMS).

ISRG vs LRCX — Head-to-Head

Bigger by revenue
LRCX
LRCX
1.9× larger
LRCX
$5.3B
$2.8B
ISRG
Growing faster (revenue YoY)
ISRG
ISRG
+0.8% gap
ISRG
23.0%
22.1%
LRCX
Higher net margin
LRCX
LRCX
0.0% more per $
LRCX
29.8%
29.8%
ISRG
Faster 2-yr revenue CAGR
LRCX
LRCX
Annualised
LRCX
18.7%
17.4%
ISRG

Income Statement — Q1 FY2026 vs Q2 FY2026

Metric
ISRG
ISRG
LRCX
LRCX
Revenue
$2.8B
$5.3B
Net Profit
$826.0M
$1.6B
Gross Margin
66.1%
49.6%
Operating Margin
33.9%
Net Margin
29.8%
29.8%
Revenue YoY
23.0%
22.1%
Net Profit YoY
17.4%
33.8%
EPS (diluted)
$2.28
$1.26

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ISRG
ISRG
LRCX
LRCX
Q1 26
$2.8B
Q4 25
$2.9B
$5.3B
Q3 25
$2.5B
$5.3B
Q2 25
$2.4B
$5.2B
Q1 25
$2.3B
$4.7B
Q4 24
$2.4B
$4.4B
Q3 24
$2.0B
$4.2B
Q2 24
$2.0B
$3.9B
Net Profit
ISRG
ISRG
LRCX
LRCX
Q1 26
$826.0M
Q4 25
$794.8M
$1.6B
Q3 25
$704.4M
$1.6B
Q2 25
$658.4M
$1.7B
Q1 25
$698.4M
$1.3B
Q4 24
$685.7M
$1.2B
Q3 24
$565.1M
$1.1B
Q2 24
$526.9M
$1.0B
Gross Margin
ISRG
ISRG
LRCX
LRCX
Q1 26
66.1%
Q4 25
66.4%
49.6%
Q3 25
66.4%
50.4%
Q2 25
66.3%
50.1%
Q1 25
64.7%
49.0%
Q4 24
68.0%
47.4%
Q3 24
67.4%
48.0%
Q2 24
68.3%
47.5%
Operating Margin
ISRG
ISRG
LRCX
LRCX
Q1 26
Q4 25
30.2%
33.9%
Q3 25
30.3%
34.4%
Q2 25
30.5%
33.7%
Q1 25
25.7%
33.1%
Q4 24
30.4%
30.5%
Q3 24
28.3%
30.3%
Q2 24
28.2%
29.1%
Net Margin
ISRG
ISRG
LRCX
LRCX
Q1 26
29.8%
Q4 25
27.7%
29.8%
Q3 25
28.1%
29.5%
Q2 25
27.0%
33.3%
Q1 25
31.0%
28.2%
Q4 24
28.4%
27.2%
Q3 24
27.7%
26.8%
Q2 24
26.2%
26.4%
EPS (diluted)
ISRG
ISRG
LRCX
LRCX
Q1 26
$2.28
Q4 25
$2.19
$1.26
Q3 25
$1.95
$1.24
Q2 25
$1.81
$1.34
Q1 25
$1.92
$1.03
Q4 24
$1.89
$0.92
Q3 24
$1.56
$0.86
Q2 24
$1.46
$7.78

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ISRG
ISRG
LRCX
LRCX
Cash + ST InvestmentsLiquidity on hand
$6.2B
Total DebtLower is stronger
$3.7B
Stockholders' EquityBook value
$17.6B
$10.1B
Total Assets
$20.1B
$21.4B
Debt / EquityLower = less leverage
0.37×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ISRG
ISRG
LRCX
LRCX
Q1 26
Q4 25
$5.9B
$6.2B
Q3 25
$4.9B
$6.7B
Q2 25
$5.3B
$6.4B
Q1 25
$4.5B
$5.5B
Q4 24
$4.0B
$5.7B
Q3 24
$4.2B
$6.1B
Q2 24
$4.8B
$5.8B
Total Debt
ISRG
ISRG
LRCX
LRCX
Q1 26
Q4 25
$3.7B
Q3 25
$3.7B
Q2 25
$3.7B
Q1 25
$3.7B
Q4 24
$4.5B
Q3 24
$4.5B
Q2 24
$4.5B
Stockholders' Equity
ISRG
ISRG
LRCX
LRCX
Q1 26
$17.6B
Q4 25
$17.8B
$10.1B
Q3 25
$16.9B
$10.2B
Q2 25
$17.8B
$9.9B
Q1 25
$17.1B
$9.5B
Q4 24
$16.4B
$8.8B
Q3 24
$15.6B
$8.5B
Q2 24
$14.7B
$8.5B
Total Assets
ISRG
ISRG
LRCX
LRCX
Q1 26
$20.1B
Q4 25
$20.5B
$21.4B
Q3 25
$19.4B
$21.9B
Q2 25
$20.2B
$21.3B
Q1 25
$19.2B
$20.0B
Q4 24
$18.7B
$19.8B
Q3 24
$17.7B
$19.5B
Q2 24
$16.6B
$18.7B
Debt / Equity
ISRG
ISRG
LRCX
LRCX
Q1 26
Q4 25
0.37×
Q3 25
0.37×
Q2 25
0.38×
Q1 25
0.39×
Q4 24
0.51×
Q3 24
0.53×
Q2 24
0.52×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ISRG
ISRG
LRCX
LRCX
Operating Cash FlowLast quarter
$1.5B
Free Cash FlowOCF − Capex
$1.2B
FCF MarginFCF / Revenue
22.8%
Capex IntensityCapex / Revenue
4.9%
Cash ConversionOCF / Net Profit
0.93×
TTM Free Cash FlowTrailing 4 quarters
$6.2B

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ISRG
ISRG
LRCX
LRCX
Q1 26
Q4 25
$892.5M
$1.5B
Q3 25
$841.0M
$1.8B
Q2 25
$715.4M
$2.6B
Q1 25
$581.6M
$1.3B
Q4 24
$822.6M
$741.9M
Q3 24
$706.5M
$1.6B
Q2 24
$620.5M
$862.4M
Free Cash Flow
ISRG
ISRG
LRCX
LRCX
Q1 26
Q4 25
$730.0M
$1.2B
Q3 25
$735.6M
$1.6B
Q2 25
$560.1M
$2.4B
Q1 25
$465.0M
$1.0B
Q4 24
$510.6M
$553.6M
Q3 24
$458.6M
$1.5B
Q2 24
$311.1M
$761.7M
FCF Margin
ISRG
ISRG
LRCX
LRCX
Q1 26
Q4 25
25.5%
22.8%
Q3 25
29.4%
29.9%
Q2 25
23.0%
46.1%
Q1 25
20.6%
21.6%
Q4 24
21.2%
12.7%
Q3 24
22.5%
35.0%
Q2 24
15.5%
19.7%
Capex Intensity
ISRG
ISRG
LRCX
LRCX
Q1 26
Q4 25
5.7%
4.9%
Q3 25
4.2%
3.5%
Q2 25
6.4%
3.3%
Q1 25
5.2%
6.1%
Q4 24
12.9%
4.3%
Q3 24
12.2%
2.7%
Q2 24
15.4%
2.6%
Cash Conversion
ISRG
ISRG
LRCX
LRCX
Q1 26
Q4 25
1.12×
0.93×
Q3 25
1.19×
1.13×
Q2 25
1.09×
1.48×
Q1 25
0.83×
0.98×
Q4 24
1.20×
0.62×
Q3 24
1.25×
1.40×
Q2 24
1.18×
0.85×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

ISRG
ISRG

Instruments and accessories$1.7B61%
Systems$650.7M23%
Services$433.7M16%

LRCX
LRCX

System$3.4B63%
Customer Supportand Other$2.0B37%

Related Comparisons